chr7-151056377-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_004935.4(CDK5):​c.312+203T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.865 in 603,802 control chromosomes in the GnomAD database, including 226,290 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.88 ( 58761 hom., cov: 32)
Exomes 𝑓: 0.86 ( 167529 hom. )

Consequence

CDK5
NM_004935.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.199

Publications

8 publications found
Variant links:
Genes affected
CDK5 (HGNC:1774): (cyclin dependent kinase 5) This gene encodes a proline-directed serine/threonine kinase that is a member of the cyclin-dependent kinase family of proteins. Unlike other members of the family, the protein encoded by this gene does not directly control cell cycle regulation. Instead the protein, which is predominantly expressed at high levels in mammalian postmitotic central nervous system neurons, functions in diverse processes such as synaptic plasticity and neuronal migration through phosphorylation of proteins required for cytoskeletal organization, endocytosis and exocytosis, and apoptosis. In humans, an allelic variant of the gene that results in undetectable levels of the protein has been associated with lethal autosomal recessive lissencephaly-7. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2015]
CDK5 Gene-Disease associations (from GenCC):
  • lissencephaly 7 with cerebellar hypoplasia
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.935 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDK5NM_004935.4 linkc.312+203T>C intron_variant Intron 5 of 11 ENST00000485972.6 NP_004926.1 Q00535-1A0A090N7W4
CDK5NM_001164410.3 linkc.312+203T>C intron_variant Intron 5 of 10 NP_001157882.1 Q00535-2A0A0S2Z355

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDK5ENST00000485972.6 linkc.312+203T>C intron_variant Intron 5 of 11 1 NM_004935.4 ENSP00000419782.1 Q00535-1

Frequencies

GnomAD3 genomes
AF:
0.878
AC:
133531
AN:
152110
Hom.:
58706
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.929
Gnomad AMI
AF:
0.845
Gnomad AMR
AF:
0.897
Gnomad ASJ
AF:
0.908
Gnomad EAS
AF:
0.957
Gnomad SAS
AF:
0.843
Gnomad FIN
AF:
0.864
Gnomad MID
AF:
0.911
Gnomad NFE
AF:
0.840
Gnomad OTH
AF:
0.875
GnomAD4 exome
AF:
0.860
AC:
388364
AN:
451574
Hom.:
167529
Cov.:
4
AF XY:
0.859
AC XY:
204465
AN XY:
238110
show subpopulations
African (AFR)
AF:
0.932
AC:
11654
AN:
12508
American (AMR)
AF:
0.912
AC:
17418
AN:
19104
Ashkenazi Jewish (ASJ)
AF:
0.902
AC:
12494
AN:
13856
East Asian (EAS)
AF:
0.977
AC:
30558
AN:
31264
South Asian (SAS)
AF:
0.849
AC:
38623
AN:
45470
European-Finnish (FIN)
AF:
0.863
AC:
25962
AN:
30074
Middle Eastern (MID)
AF:
0.865
AC:
1713
AN:
1980
European-Non Finnish (NFE)
AF:
0.838
AC:
227303
AN:
271160
Other (OTH)
AF:
0.865
AC:
22639
AN:
26158
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
2865
5730
8596
11461
14326
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
916
1832
2748
3664
4580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.878
AC:
133643
AN:
152228
Hom.:
58761
Cov.:
32
AF XY:
0.878
AC XY:
65347
AN XY:
74428
show subpopulations
African (AFR)
AF:
0.929
AC:
38590
AN:
41530
American (AMR)
AF:
0.898
AC:
13718
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.908
AC:
3151
AN:
3470
East Asian (EAS)
AF:
0.957
AC:
4956
AN:
5180
South Asian (SAS)
AF:
0.843
AC:
4070
AN:
4830
European-Finnish (FIN)
AF:
0.864
AC:
9169
AN:
10610
Middle Eastern (MID)
AF:
0.918
AC:
270
AN:
294
European-Non Finnish (NFE)
AF:
0.840
AC:
57092
AN:
68002
Other (OTH)
AF:
0.877
AC:
1856
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
854
1708
2562
3416
4270
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
898
1796
2694
3592
4490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.861
Hom.:
92748
Bravo
AF:
0.884
Asia WGS
AF:
0.913
AC:
3173
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
1.9
DANN
Benign
0.55
PhyloP100
-0.20
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1549759; hg19: chr7-150753464; API